Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | PTHL |
---|---|---|
09:53 ET | 959 | 4.45 |
09:55 ET | 5350 | 4.45 |
09:57 ET | 1850 | 4.45 |
10:31 ET | 3500 | 4.39 |
10:36 ET | 500 | 4.39 |
10:47 ET | 1679 | 4.3 |
11:05 ET | 580 | 4.49 |
11:43 ET | 100 | 4.4 |
12:12 ET | 300 | 4.45 |
12:14 ET | 400 | 4.4 |
12:15 ET | 2040 | 4.4206 |
01:06 ET | 2600 | 4.5 |
01:08 ET | 10674 | 4.5371 |
01:09 ET | 7687 | 4.46 |
01:13 ET | 100 | 4.49 |
01:15 ET | 100 | 4.48 |
01:18 ET | 6985 | 4.45 |
01:20 ET | 100 | 4.49 |
01:26 ET | 600 | 4.45 |
01:27 ET | 200 | 4.47 |
01:29 ET | 3000 | 4.42 |
01:31 ET | 13448 | 4.28 |
01:33 ET | 9143 | 4.27 |
01:36 ET | 800 | 4.2401 |
01:38 ET | 6900 | 4.25 |
01:40 ET | 5100 | 4.3 |
01:42 ET | 3100 | 4.29 |
01:44 ET | 1395 | 4.31 |
01:49 ET | 100 | 4.3 |
01:51 ET | 5676 | 4.31 |
01:54 ET | 10900 | 4.32 |
02:09 ET | 100 | 4.33 |
02:12 ET | 1047 | 4.33 |
02:25 ET | 400 | 4.33 |
02:30 ET | 400 | 4.33 |
02:32 ET | 300 | 4.33 |
02:34 ET | 800 | 4.32 |
02:36 ET | 600 | 4.34 |
02:39 ET | 100 | 4.34 |
02:45 ET | 200 | 4.34 |
02:50 ET | 100 | 4.34 |
02:52 ET | 100 | 4.34 |
03:01 ET | 100 | 4.33 |
03:08 ET | 400 | 4.33 |
03:12 ET | 200 | 4.34 |
03:14 ET | 300 | 4.33 |
03:15 ET | 200 | 4.33 |
03:24 ET | 100 | 4.33 |
03:33 ET | 100 | 4.32 |
03:35 ET | 500 | 4.33 |
03:46 ET | 3061 | 4.43 |
03:48 ET | 135 | 4.41 |
03:50 ET | 500 | 4.38 |
03:51 ET | 11544 | 4.38 |
04:00 ET | 1909 | 4.31 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Pheton Holdings Ltd | 61.4M | -214.4x | --- |
Heartbeam Inc | 68.3M | -4.0x | --- |
Harvard Apparatus Regenerative Technology Inc | 50.1M | -6.1x | --- |
Vicarious Surgical Inc | 49.5M | -0.8x | --- |
Singular Genomics Systems Inc | 56.9M | -0.6x | --- |
Vivos Inc | 46.4M | -14.9x | --- |
Pheton Holdings Ltd is a China-based holding company. The Company is focused on the development and commercialization of treatment software used for brachytherapy through its subsidiary Beijing Feitian Zhaoye Technology Co., Ltd., (Beijing Feitian). Beijing Feitian's proprietary treatment planning system (TPS) product, Feitian Treatment Planning Software (FTTPS), is designed to promote the efficiency, accuracy, and safety of brachytherapy. The Company's operations also include the sales of medical auxiliary supplies, such as seed implant needles, computer workstations and others, as well as sales of FTTPS-related technical advisories or provisions of consulting services.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $61.4M |
---|---|
Revenue (TTM) | $628.6K |
Shares Outstanding | 14.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.02 |
Book Value | $0.03 |
P/E Ratio | -214.4x |
Price/Sales (TTM) | 97.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -48.79% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.